View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AM20 Publication ID: Fall 2002 
Title: ●Time Limitation on Recalculations and Disputes Under the Drug Rebate Program (CMS-2175-IFC) 
Abstract: This rule will establish a three year time limitation on drug manufacturer's requests to recalculate their drug prices for the purposes of reporting data to CMS, as well as manufacturer's ability to dispute claims for rebates. 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Undetermined  Unfunded Mandates: No 
CFR Citation: 42 CFR 447.534   
Legal Authority: 42 USC 1396r-8   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  12/00/2002    
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: Federal, State 
Small Entities Affected: Businesses  Federalism: Undetermined 
Included in the Regulatory Plan: No 
Agency Contact:
Wendy Tuttle
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
S1-01-16, Center for Medicaid and CHIP Services, MS: S2-14-26, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-8690
Email: wendy.tuttle@cms.hhs.gov